Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model. - Wikidata - wikimedia - TriplyDB

Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.

Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.

http://www.wikidata.org/entity/Q40213039

about

K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis MicroRNAs in neutrophils: potential next generation therapeutics for inflammatory ailments.Arthritis models: usefulness and interpretation.Complement Receptors in Myeloid Cell Adhesion and Phagocytosis.A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.Antibodies to Type IV Collagen Induce Type 1 Autoimmune Pancreatitis.Complement in the Initiation and Evolution of Rheumatoid Arthritis.

P2860

Q26745541-EFDADCC7-2E74-4FA7-BBBF-21DB08D5FE62 Q38828119-6D13A906-EEC4-444D-8ADC-88E71025269F Q38872112-58A370A9-845E-4073-B27B-3BA9CCE27194 Q38997578-989D0236-16D1-4B0A-AB60-52AF5F552AA2 Q40734548-D44C9D43-1DB1-420B-B672-C5E7D7770842 Q41010289-979A7F66-6FE8-47C6-84E8-17F6EC8216F0 Q47129297-F09F2693-3721-4937-A622-6F6B802724E2 Q50277552-41307314-76BD-4F66-B5FB-6D6021C2E649 Q51645105-AC143F08-54B5-464A-AE3E-64E75747A93F Q55050150-A0F0523D-E018-41AA-87B9-36A7E7529326

P2860

Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.

http://www.wikidata.org/entity/Q40213039

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Rapid-onset clinical and mecha ...... lagen-induced arthritis model.

@en

type

label

Rapid-onset clinical and mecha ...... lagen-induced arthritis model.

@en

prefLabel

Rapid-onset clinical and mecha ...... lagen-induced arthritis model.

@en

P1433

Q40213039-83755143-0101-431B-B71D-679F5EED98A4

P1476

Q40213039-02FEE6F6-2D27-4236-A33A-5BDFCDDE9E45

P2093

Q40213039-0E642E42-16BC-4B0D-AF5D-98208A9296FD

Q40213039-15693306-53DF-4FBC-B82B-B9BF542E6B86

Q40213039-1F8BF17B-E151-4B35-92FA-D3FCEDB6BFE2

Q40213039-2E5B16A7-6FE6-4BBE-AC18-D9F48CF8950F

Q40213039-4702184D-8AE2-4DAA-92CB-153E9C667D45

Q40213039-518D2959-95AC-4478-9F86-948A87FE2915

Q40213039-5366F618-823E-41F0-B8C9-87B0E3D15270

Q40213039-BB95DB30-D5F5-4390-BFFB-8840D51650EE

Q40213039-C6FB7C5B-1E05-478F-86FC-1C17BB05D3C0

Q40213039-F1A12A43-7B8C-420A-B990-6923101C3DB9

P2860

Q40213039-0DC505BF-B048-45B0-8009-2CA40CC58EB9

Q40213039-0E719F42-6E88-4DF5-92F8-028F9656B60C

Q40213039-1299A217-7103-4ABB-93B1-5AE0E293312A

Q40213039-212AA42A-6406-4402-B063-B6DFDE54EE84

Q40213039-24931374-99DE-485D-9BD9-8FA095C85D33

Q40213039-2EBD4250-853E-4C31-8E69-C68401A3B607

Q40213039-2F9FCE1E-B96D-4F26-93AD-FFEC0AFA4890

Q40213039-374553D5-4BF7-4BA5-A80D-CDF73BAC31C1

Q40213039-3C5088D1-4849-4B99-A855-30A3D3C4ED4E

Q40213039-3F64E278-6925-430F-9BE9-F2F115E60BBB

P304

Q40213039-8B0BFE03-EA00-48F4-BAD5-8AD9EB31C52A

P31

Q40213039-AC5F3290-0BBC-450B-9106-4B013891CA06

P356

Q40213039-0FF753BC-A95C-4BF3-BAE9-8DE1A16DF015

P433

Q40213039-982D3DE7-3A30-4163-8277-3325F815DA92

P478

Q40213039-FB878E3F-6D1E-4AAC-B278-A91423F19DD3

P50

Q40213039-69A1139E-F446-43E4-8FDF-4492623781C0

P577

Q40213039-69EBEF72-19B6-420B-8CF0-DF076F3EFB17

P698

Q40213039-E9CC0EAE-30FD-4ABA-B6AB-282BC832E63C

P932

Q40213039-C4656F05-0046-42FD-8306-AF9938B040A4

P356

P1433

Clinical and Experimental Immunology

P1476

Rapid-onset clinical and mecha ...... lagen-induced arthritis model.

@en

P2093

B Friedrichsen

http://www.w3.org/2001/XMLSchema#string

B Rønø

http://www.w3.org/2001/XMLSchema#string

B-C Sondergaard

http://www.w3.org/2001/XMLSchema#string

C Andersson

http://www.w3.org/2001/XMLSchema#string

C Chang

http://www.w3.org/2001/XMLSchema#string

C S Wenander

http://www.w3.org/2001/XMLSchema#string

J B Hebsgaard

http://www.w3.org/2001/XMLSchema#string

L Hornum

http://www.w3.org/2001/XMLSchema#string

P A Usher

http://www.w3.org/2001/XMLSchema#string

R Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in rheumatology: new targeted therapeutics

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis

A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis

The pathogenesis of rheumatoid arthritis

Neutrophil recruitment and function in health and inflammation

Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.

Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.

Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.

The new face of anaphylatoxins in immune regulation.

P304

219-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.12338

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Charles R. Mackay

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24665841

http://www.w3.org/2001/XMLSchema#string

P932

4089171

http://www.w3.org/2001/XMLSchema#string